Press Releases about Ambrx Biopharma Inc ADR
![](https://mms.businesswire.com/media/20240210714862/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240110579626/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9c3ffae4-603d-404f-93cf-1106337e9e0b/small/finacialnews-logo-final-01-2-png.png)
![](https://mms.businesswire.com/media/20240108564838/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20230313005262/en/1736310/22/Ambrx_Logo.jpg)
Ambrx Raises $78 Million and Completes its ATM Program
March 13, 2023
From Ambrx, Inc.
Via Business Wire
![](https://www.marketbeat.com/logos/articles/small_20230307104409_potential-earnings-have-rated-ambrx-biopharma-a-bu.jpg)
![](https://mms.businesswire.com/media/20230306005318/en/1730324/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20230301005529/en/1726812/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20230216005191/en/1715314/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20230213005207/en/1711467/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20230203005110/en/1704612/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20221216005508/en/1667955/22/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20221209005110/en/1660332/5/AMBRX_Logo.jpg)
![](https://mms.businesswire.com/media/20221109005345/en/1546191/4/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20221101006251/en/1546191/4/Ambrx_Logo.jpg)
Ambrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
November 01, 2022
From Ambrx
Via Business Wire
![](https://mms.businesswire.com/media/20220829005608/en/1546191/4/Ambrx_Logo.jpg)
Ambrx Biopharma Inc. Reports 1H 2022 Financial Results and Provides Corporate Update
August 29, 2022
From Ambrx, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220816005844/en/1546033/4/Ambrx_Logo.jpg)
From Ambrx, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220705005732/en/1504962/4/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20220628006027/en/1499680/4/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20220602005175/en/1473697/4/Ambrx_Logo.jpg)
From Ambrx, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220527005400/en/1469786/4/Ambrx_Logo.jpg)
From Ambrx, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220517006174/en/1458906/4/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20220506005493/en/1446817/4/Ambrx_Logo.jpg)
From Ambrx, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220502005647/en/1439864/4/Ambrx_Logo.jpg)
![](https://mms.businesswire.com/media/20220426006131/en/1433484/4/Ambrx_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.